Medicare CGM eligibility widened in potential boon for Abbott, Dexcom

The Centers for Medicare and Medicaid Services opened up Medicare coverage for therapeutic continuous glucose monitors, eliminating a rule that beneficiaries must use a blood glucose monitor and require at least four self-monitoring blood glucose (SMBG) tests per day to have devices covered.